Patents by Inventor Amy Beckley
Amy Beckley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240058805Abstract: Embodiments of the invention comprise a test strip configured to detect one or more metabolites of progesterone in urine, and optionally further detect one or more additional metabolites or hormones in urine within the same test strip. Embodiments of the invention are methods of utilizing such a test strip in association with avoidance of pregnancy, detection of menopause, and in association with fertility planning purposes. Embodiments of the invention are associated with the incorporation of a test strip within a testing kit, optionally further comprising a digital reader.Type: ApplicationFiled: March 23, 2023Publication date: February 22, 2024Applicant: MFB Fertility, Inc.Inventor: Amy BECKLEY
-
Publication number: 20230408512Abstract: Embodiments of the invention comprise a test strip configured to detect one or more metabolites of progesterone in urine, and optionally further detect one or more additional metabolites or hormones in urine within the same test strip. Embodiments of the invention are methods of utilizing such a test strip in association with avoidance of pregnancy, detection of menopause, and in association with fertility planning purposes. Embodiments of the invention are associated with the incorporation of a test strip within a testing kit, optionally further comprising a digital reader.Type: ApplicationFiled: January 6, 2023Publication date: December 21, 2023Applicant: MFB Fertility, Inc.Inventor: Amy BECKLEY
-
Publication number: 20230064561Abstract: Provided herein are systems and methods that use an electrochemical aptamer-based (EAB) biosensor to detect a plurality of hormone and/or analyte that can be used for fertility and pregnancy monitoring.Type: ApplicationFiled: August 27, 2022Publication date: March 2, 2023Applicant: MFB Fertility, Inc.Inventor: Amy BECKLEY
-
Publication number: 20230068803Abstract: Provided herein are devices and methods for monitoring biofluids related to ovulation. Such devices include the use of electrochemical aptamer-based (EAB) sensors.Type: ApplicationFiled: August 27, 2022Publication date: March 2, 2023Applicants: UNIVERSITY OF CINCINNATI, MFB FERTILITY, INC.Inventors: Jason HEIKENFELD, Amy BECKLEY
-
Patent number: 11573225Abstract: Various aspects of the system and methods described herein rely upon the operation of lateral flow assays specially configured to evaluate a bodily fluid for at least the presence or absence of pregnanediol glucuronide at a threshold selected from the range inclusive of 1 ?g/mL-10 ?g/mL. The results from the lateral flow assays are optionally interpreted in association with an application operating upon a mobile device or a system for the collection, interpretation and storage of results. The interpretations are useful in accordance with facilitating diagnoses and treatments associated with medical conditions related to the generated interpretations of the lateral flow assays.Type: GrantFiled: May 11, 2021Date of Patent: February 7, 2023Assignee: MFB Fertility, Inc.Inventor: Amy Beckley
-
Publication number: 20220341951Abstract: The present invention relates to a system and methods for evaluating and tracking the operation of the menstrual cycle and treating undesirable trends associated with the menstrual cycle. Various aspects of the system and methods described herein rely upon the operation of diagnostic tests specially configured to evaluate a bodily fluid for the presence or absence of hormones or analytes, and more specifically configured to evaluate a bodily fluid for at least the presence or absence of pregnanediol glucuronide at a threshold selected from the range inclusive of 1 ?g/mL-10 ?g/mL. The results from one or more diagnostic tests are interpreted in accordance with the teachings of the system.Type: ApplicationFiled: July 2, 2020Publication date: October 27, 2022Applicant: MFB Fertility, Inc.Inventors: Amy BECKLEY, Jeffrey SCHELL, Ellen SCHELL
-
Publication number: 20210389311Abstract: Disclosed herein are devices, systems, methods and kits for performing immunoassay tests to detect for at least progesterone or analytes of progesterone on a sample in association with diagnosing problems and issues associated with corpus luteum functionality. The immunoassay devices and methods may be used in conjunction with diagnostic reader systems and/or a base unit for obtaining a sensitive readout of the immunoassay results. The methods disclosed herein may also incorporate steps associated with evaluating the urine of a sample for the presence of an estrogen metabolite and/or luteinizing hormone.Type: ApplicationFiled: August 30, 2021Publication date: December 16, 2021Applicant: MFB Fertility, Inc.Inventor: Amy Beckley
-
Patent number: 11131665Abstract: Disclosed herein are devices, systems, methods and kits for performing immunoassay tests to detect for at least progesterone or analytes of progesterone on a sample in association with diagnosing problems and issues associated with corpus luteum functionality. The immunoassay devices and methods may be used in conjunction with diagnostic reader systems and/or a base unit for obtaining a sensitive read-out of the immunoassay results. The immunoassay devices and methods may utilize a competitive binding-like assay and a sandwich binding assay to detect at least progesterone or analytes of progesterone in a sample.Type: GrantFiled: May 5, 2021Date of Patent: September 28, 2021Assignee: MFB Fertility, Inc.Inventor: Amy Beckley
-
Publication number: 20210293809Abstract: Various aspects of the system and methods described herein rely upon the operation of lateral flow assays specially configured to evaluate a bodily fluid for at least the presence or absence of pregnanediol glucuronide at a threshold selected from the range inclusive of 1 ?g/mL-10 ?g/mL. The results from the lateral flow assays are optionally interpreted in association with an application operating upon a mobile device or a system for the collection, interpretation and storage of results. The interpretations are useful in accordance with facilitating diagnoses and treatments associated with medical conditions related to the generated interpretations of the lateral flow assays.Type: ApplicationFiled: May 11, 2021Publication date: September 23, 2021Applicant: MFB Fertility,Inc.Inventor: Amy Beckley
-
Publication number: 20210293800Abstract: Disclosed herein are devices, systems, methods and kits for performing immunoassay tests to detect for at least progesterone or analytes of progesterone on a sample in association with diagnosing problems and issues associated with corpus luteum functionality. The immunoassay devices and methods may be used in conjunction with diagnostic reader systems and/or a base unit for obtaining a sensitive read-out of the immunoassay results. The immunoassay devices and methods may utilize a competitive binding-like assay and a sandwich binding assay to detect at least progesterone or analytes of progesterone in a sample.Type: ApplicationFiled: May 5, 2021Publication date: September 23, 2021Applicant: MFB Fertility, Inc.Inventor: Amy Beckley
-
Patent number: 11061026Abstract: Disclosed herein are devices, systems, methods and kits for performing immunoassay tests to detect for at least progesterone or analytes of progesterone on a sample in association with diagnosing problems and issues associated with corpus luteum functionality. The immunoassay devices and methods may be used in conjunction with diagnostic reader systems and/or a base unit for obtaining a sensitive read-out of the immunoassay results. The immunoassay devices and methods may utilize a competitive binding-like assay and a sandwich binding assay to detect at least progesterone or analytes of progesterone in a sample.Type: GrantFiled: January 2, 2020Date of Patent: July 13, 2021Assignee: MFB Fertility, Inc.Inventor: Amy Beckley
-
Patent number: 11029321Abstract: Disclosed herein are methods, for use in association with specially configured devices, systems, and kits, for performing immunoassay tests to detect for at least progesterone or analytes of progesterone on a sample in association with diagnosing problems and issues associated with corpus luteum functionality. The immunoassay devices and methods may be used in conjunction with diagnostic reader systems and/or a base unit for obtaining a sensitive read-out of the immunoassay results. The immunoassay devices and methods may utilize a competitive binding-like assay and a sandwich binding assay to detect at least progesterone or analytes of progesterone in a sample.Type: GrantFiled: January 2, 2020Date of Patent: June 8, 2021Assignee: MFB Fertility, Inc.Inventor: Amy Beckley
-
Publication number: 20210055310Abstract: An in-home lateral flow assay test strip that can be used to monitor PdG levels in urine, which correlate with progesterone levels in serum. The lateral flow test strip is a competitive assay comprising a sample pad, conjugate pad, membrane strip, backing card, an adsorbent pad, a test line impregnated onto the membrane strip comprised of pregnanediol glucuronide (PdG) conjugated to immunoglobulin G (IgG), bovine serum albumin (BSA), bovine gamma globulin (BGG) or another suitable carrier protein and a control line impregnated onto the membrane strip comprised of anti-mouse antibodies. The conjugate pad is saturated with mouse monoclonal anti-PdG antibodies conjugated to colloidal gold, latex beads, or similar visual dye. The test strip may be encased in a cassette such that only the wicking pad and detection zone are visible to the user.Type: ApplicationFiled: August 19, 2019Publication date: February 25, 2021Inventor: AMY BECKLEY
-
Publication number: 20200141954Abstract: Disclosed herein are devices, systems, methods and kits for performing immunoassay tests to detect for at least progesterone or analytes of progesterone on a sample in association with diagnosing problems and issues associated with corpus luteum functionality. The immunoassay devices and methods may be used in conjunction with diagnostic reader systems and/or a base unit for obtaining a sensitive read-out of the immunoassay results. The immunoassay devices and methods may utilize a competitive binding-like assay and a sandwich binding assay to detect at least progesterone or analytes of progesterone in a sample.Type: ApplicationFiled: January 2, 2020Publication date: May 7, 2020Applicant: MFB Fertility, Inc.Inventor: Amy Beckley
-
Publication number: 20200141953Abstract: Disclosed herein are methods, for use in association with specially configured devices, systems, and kits, for performing immunoassay tests to detect for at least progesterone or analytes of progesterone on a sample in association with diagnosing problems and issues associated with corpus luteum functionality. The immunoassay devices and methods may be used in conjunction with diagnostic reader systems and/or a base unit for obtaining a sensitive read-out of the immunoassay results. The immunoassay devices and methods may utilize a competitive binding-like assay and a sandwich binding assay to detect at least progesterone or analytes of progesterone in a sample.Type: ApplicationFiled: January 2, 2020Publication date: May 7, 2020Applicant: MFB Fertility, Inc.Inventor: Amy Beckley
-
Publication number: 20200078781Abstract: Embodiments of the invention comprise a test strip configured to detect one or more metabolites of progesterone in urine, and optionally further detect one or more additional metabolites or hormones in urine within the same test strip. Embodiments of the invention are methods of utilizing such a test strip in association with avoidance of pregnancy, detection of menopause, and in association with fertility planning purposes. Embodiments of the invention are associated with the incorporation of a test strip within a testing kit, optionally further comprising a digital reader.Type: ApplicationFiled: December 28, 2018Publication date: March 12, 2020Applicant: MFB Fertility, Inc.Inventor: Amy Beckley
-
Publication number: 20180321251Abstract: The preferred embodiment of the resent invention is described as an in-home diagnostic system used to monitor ovulation cycles. In embodiments, the invention allows for users to evaluate early pregnancy status without medical training. Embodiments of the invention comprise a method incorporating usage of a smart device to allow for analysis of multiple analytes present within a single sample placed upon a lateral flow assay test cassette.Type: ApplicationFiled: May 8, 2018Publication date: November 8, 2018Applicant: MFB Fertility, Inc.Inventor: Amy Beckley
-
Publication number: 20150086587Abstract: Oil-based adjuvant emulsions, immunogenic compositions, and methods of using the same to elicit immunological responses in a subject are provided. The oil-based adjuvants comprise a plant-derived surfactant, such as gum arabic, an aqueous component, and an oil. The adjuvant emulsions can be used to potentiate the immunological effects of active agents, including antigens derived from various pathogens and/or toxins. Immunogenic compositions comprising the adjuvant emulsions and various active agents are also provided, along with vaccine systems for therapeutic or prophylactic treatment of a subject using these adjuvants.Type: ApplicationFiled: March 28, 2013Publication date: March 26, 2015Inventors: Jishu Shi, Loretta Pappan, Amy Beckley, Qixin Zhong